RECRUITING

Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

Talk to us

Conditions

Blood ClotsVascular DiseaseEmbolism ThrombosisCardiovascular DiseasesLung Diseasesthrombolysispulmonary catheterhemodynamic monitoringcatheter directed therapy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Assess the functionality of the Versus Catheter for catheter-directed thrombolysis of pulmonary blood clots, including advanced imaging assessment. An evaluation of patient outcomes from the cases included in this study will also be conducted.

Official Title

Single Center Post-Market Study of Thrombolytic Therapy Using the Versus™ Catheter

Quick Facts

Study Start:2025-09-05
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06975969

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients 18 - 80 years, inclusive
  2. * Patients who present with submassive pulmonary embolism (PE)
  3. * Patients requiring thrombolytic intervention to the pulmonary vasculature
  4. * Physician decision to use the Versus™ Catheter during the treatment of the patient
  1. * Concurrent treatment with thrombectomy
  2. * Concurrent treatment with a catheter-directed thrombolysis device that is NOT the Versus™ Catheter
  3. * Massive pulmonary embolism (PE)
  4. * Active bleeding disorder1
  5. * Recent cerebrovascular accident or transient ischemic attack1
  6. * Recent neurosurgery1
  7. * Recent intracranial trauma1
  8. * Absolute contraindication to anticoagulation1
  9. * BMI \> 45kg/m2
  10. * In the opinion of the investigator, the participant is not a suitable candidate for the study

Contacts and Locations

Study Contact

Derek Hall, MS
CONTACT
301-337-8159
d.hall@liquetmedical.com
Carrie Kuehn, MA, MPH, LPD, RAC-US
CONTACT
301-337-8159
c.kuehn@liquetmedical.com

Principal Investigator

Luke Wilkins, MD
PRINCIPAL_INVESTIGATOR
University of Virgina (UVA)

Study Locations (Sites)

University of Virginia Medical Center
Charlottesville, Virginia, 22903
United States

Collaborators and Investigators

Sponsor: Liquet Medical Inc.

  • Luke Wilkins, MD, PRINCIPAL_INVESTIGATOR, University of Virgina (UVA)

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-09-05
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2025-09-05
Study Completion Date2025-12-31

Terms related to this study

Keywords Provided by Researchers

  • thrombolysis
  • pulmonary catheter
  • hemodynamic monitoring
  • catheter directed therapy

Additional Relevant MeSH Terms

  • Blood Clots
  • Vascular Disease
  • Embolism Thrombosis
  • Cardiovascular Diseases
  • Lung Diseases